This topic contains a solution. Click here to go to the answer

Author Question: Which holy man created the first community of monks in Egypt and laid the foundations for the ... (Read 269 times)

bobbie

  • Hero Member
  • *****
  • Posts: 592

Question 1

Based on the text's presentation, which of the following does NOT apply to Polybius?
 
  a. praise for Rome's balance of aristocratic and democratic elements
  b. belief that a historian should try to teach moral lessons
  c. admiration of the Roman army's discipline and dedication
  d. criticism of Thucydides
  e. a systematic world history that examines the general and comprehensive scheme of events

Question 2

Which holy man created the first community of monks in Egypt and laid the foundations for the monastic movement?
 
  a. Saint Martin
  b. Saint Augustine
  c. Saint Jerome
  d. Saint Anthony
  e. Saint Aquinas



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

sabina576

  • Sr. Member
  • ****
  • Posts: 356


sabina576

  • Sr. Member
  • ****
  • Posts: 356

 

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Only 12 hours after an egg cell is fertilized by a sperm cell, the egg cell starts to divide. As it continues to divide, it moves along the fallopian tube toward the uterus at about 1 inch per day.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library